Dr. Senjuti Saha Gets Appointed as Member of WHO Product Development for Vaccines Advisory Committee (PDVAC)

03 July, 2023
PDVAC is an independent standing WHO committee of experts which provides external advice to WHO related to priority infectious disease pathogens, associated vaccine and monoclonal antibody product development approaches and related manufacturing and delivery technologies. The committee’s remit covers disease areas where there is, or may be, substantial disease burden in low- and middle-income countries (LMICs), where no vaccine related products currently exist, but where there is ongoing product development activity which may benefit from WHO guidance, or technologies that could expedite availability and access of vaccine products in LMICs.
PDVAC’s mission is to accelerate product development of vaccines and technologies that are urgently needed and ensure they are appropriately targeted for use in low and middle income contexts.

Upon being appointed as a member, CHRF's Director & Senior Scientist, Dr. Senjuti Saha said, 'I returned to Bangladesh to specifically work on diseases that affect Bangladeshi children, for which we need new vaccines, and this is a step towards that.'

Find the full list of members here: https://www.who.int/groups/product-development-for-vaccines-advisory-committee/members?fbclid=IwAR31iSUsrZk7VzZ1Jat7ThL_O0s5gSQhC5ebMQqMDdwMXhaqliOjr2TM0-g